Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
Morning Rats/Rob,
Couldn"t agree more guys and said just about the same thing yesterday. With a CV like what our new chairman has he must have seen many reasons to add Scancell to it, and given his CV I can see many reasons why we would want him at the helm.
Lets face it when Chiplin joined there were some big stragegic decisions to make as indeed there are now. It looks to me a perfect fit.
A great appointment. The man has a tremendous CV and there must have been a lot to like about Scancel, where we are and where we are to make it happen.
Another chance for me to thank Chiplin for where he has taken us untin now.
What an excellent interview with RG, thanks for posting it. I think we all are dying to know what the deal with Genmab was upfront and RG explained it as a very, very nice deal, he stated all patients are showing immune responses which is awesome, and something we have disagreed on over the years is Scancell holding on to a major RNS AS THEY DID FROM 2011 TO 2012 related to Moditope whilst we applied for Patents. We have been told numerous times we have to announce price changing info as it occurs, that is obviousely not the case.
I have the utmost respect for RG AND FEEL MORE CONFIDENT THAN EVER AFTER HEARING THAT INTERVIEW, AND FOR PEOPLE who worry we are not known well enough, well he said it was no coincidence Redmile came about after a 20 year relationship with Genmab. The story with Roche and he limousine bought a smile to my face to.
Onwards, forwards, keep punching!!!
roses, deal/s already done? In the pipeline? well yes that is what I am suggesting, uderstand what you mean aout not attending but if it is news that we are hoping for it can only be positive attending